Quarterly report pursuant to Section 13 or 15(d)

The following unaudited pro forma consolidated financial information reflects the results of operations of the Company for the three and six months ended June 30, 2023 and 2022 as if the USL Acquisition had occurred as of January 1, 2022 and gives effect (Details)

v3.23.2
The following unaudited pro forma consolidated financial information reflects the results of operations of the Company for the three and six months ended June 30, 2023 and 2022 as if the USL Acquisition had occurred as of January 1, 2022 and gives effect (Details) - Upsher-Smith Laboratories, LLC [Member] - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Business Acquisition [Line Items]        
Net Product Sales $ 3,544 $ 4,735 $ 7,621 $ 3,977
Net Loss $ (29,730) $ (26,364) $ (64,180) $ (61,375)